Byrne Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9
| Closed | -$1.08K | – | 547 |
|
|
2024
Q1 | $1.08K | Sell |
9
-22
| -71% | -$2.65K | ﹤0.01% | 512 |
|
|
2023
Q4 | $3.8K | Sell |
31
-15
| -33% | -$1.84K | ﹤0.01% | 447 |
|
|
2023
Q3 | $6K | Hold |
46
| – | – | 0.01% | 384 |
|
|
2023
Q2 | $6K | Hold |
46
| – | – | ﹤0.01% | 449 |
|
|
2023
Q1 | $7K | Hold |
46
| – | – | 0.01% | 425 |
|
|
2022
Q4 | $7.33K | Sell |
46
-10
| -18% | -$1.59K | 0.01% | 410 |
|
|
2022
Q3 | $7K | Sell |
56
-50
| -47% | -$6.25K | 0.01% | 378 |
|
|
2022
Q2 | $17K | Sell |
106
-74
| -41% | -$11.9K | 0.01% | 302 |
|
|
2022
Q1 | $28K | Hold |
180
| – | – | 0.02% | 267 |
|
|
2021
Q4 | $23K | Buy |
+180
| New | +$23K | 0.01% | 279 |
|